Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director MAYLEBEN TIMOTHY M
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Girao Tiago
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Callori Fred
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Batycky Alka
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Adsett Roger
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Garabedian Christopher Nishan
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Cataldi Fabio
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Oakes Gregory
Landos Biopharma | RW: Registration Withdrawal Request
Landos Biopharma | S-8 POS: S-8 POS
Landos Biopharma | S-8 POS: S-8 POS
Landos Biopharma | S-8 POS: S-8 POS
Landos Biopharma | S-8 POS: S-8 POS
Landos Biopharma | 8-K: Current report
Landos Biopharma | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Landos Biopharma | 8-K: Current report
Landos Biopharma | 10-Q: Quarterly report
Landos Biopharma | DEFM14A: Definitive proxy statement relating to merger or acquisition
Landos Biopharma | 10-K/A: Annual report (Amendment)
Landos Biopharma | PREM14A: Preliminary proxy statements relating to merger or acquisition
No Data